Intuitive Surgical's Growth Slowdown Sparks Buying Opportunity

Intuitive Surgical, a pioneer in surgical robotics, has seen its growth slow down significantly since the post-pandemic highs. The company's da Vinci system was one of the first and most widely available options, and it initially grew rapidly due to its advantages over traditional surgery methods.

The market for surgical robots has become increasingly competitive, with medical device giants like Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) entering the fray. This increased competition has led to a slowdown in Intuitive Surgical's business, which is now facing material competition from well-heeled competitors.

However, it's worth noting that Intuitive Surgical's biggest business isn't selling new robots; rather, it's the maintenance and servicing of existing da Vinci systems, which account for 75% of its top line. This annuity-like income stream will continue to provide a steady revenue source until the da Vinci systems are no longer in use.

The company also sees opportunities for growth through continued technological advances, particularly in artificial intelligence (AI) and its potential applications in robotic surgery. Historically, Intuitive Surgical has recovered from each drawdown and gone on to higher highs, suggesting that the current sell-off could be a buying opportunity.